E-Prosiding Persidangan Serantau Manasik Haji 2025 (MANASIK2025)

MANASIK2025 Putrajaya, Malaysia, 7-8 Oktober 2025 768 Kunūz Ishbīliya liʾl -Nashr wa-l- Tawzīʿ, 1429 H/2008 M. 11. Ḥātim al- Ḥājj. Athar taṭawwur al- maʿārif al- ṭibbiyya ʿalā taghayyur al- fatwā wa-l- qaḍāʾ. 2nd ed. al- Qāhira: Dār Bilāl ibn Rabāḥ; Dār Ibn Ḥazm, 2019. 12. Ibn ʿAbd al-Barr, Yūsuf b. ʿAbd Allāh. Al- Istidhkār. Beirut: Dār al-Kutub al- ʿIlmiyyah, 2000. 13. Ibn Qudāmah al- Maqdisī. Al- Mughnī. Beirut: Dār al-Fikr, 1997. 14. Isabelle, P. L. U., D. Ragonnetu, B. Begue, E. Toubin, and I. Purssell- FranÇOis. “Permanent Disability: When and How Should It Be Determined?” Journal de Medecine Legale Droit Medical 51, no. 4 – 5 (2008): 263 – 70. 15. Kementerian Kesihatan Malaysia dan Lembaga Tabung Haji. Garis Panduan Pemeriksaan KesihatanBakalHaji Edisi 10 .Cetakanke-15.KualaLumpur:LembagaTabungHaji,2024. 16. Krishnan, M., J. S. Temel, A. A. Wright, R. Bernacki, K. Selvaggi, and T. Balboni. “Predicting Life Expectancy in Patients with Advanced Incurable Cancer: A Review.” Journal of Supportive Oncology 11, no. 2 (2013): 68 – 74 . https://doi.org/10.12788/j.suponc.0004. 17. Li, R., M. Robinson, X. Ding, T. Geetha, L. Al-Nakkash, T. L. Broderick, and J. R. Babu. “Genistein: A Focus on Several Neurodegenerative Diseases.” Journal of Food Biochemistry 46, no. 7 (2022): e14155 . https://doi.org/10.1111/jfbc.14155. 18. Majmūʿa min al- muʾallifīn. Majallat Majmaʿ al -Fiqh al- Islāmī. Jeddah: Majmaʿ al -Fiqh al- Islāmī, n.d. 19. Majmūʿa min al- muʾallifīn. al- Mawsūʿa al-Fiqhiyya al-Kuwaytiyya. 1st ed. 1427H/2006M. 20. Mangka, Jahada, Muhamad Saddam Nurdin, and Nurfaikah Nasrulla. “Keabsahan Badal Haji Pada Mubaddil Yang Belum Pernah Melaksanakan Haji (Studi Komparatif Mazhab Maliki Dan Syafii).” Al- Ǫiblah 3, no. 3 (2024): 387 – 413 . https://doi.org/10.36701/qiblah.v3i3.1600. 21. Metta, V., L. Batzu, V. Leta, D. Trivedi, A. Powdleska, K. R. Mridula, P. Kukle, et al. “Parkinson’s Disease: Personalized Pathway of Care for Device-Aided Therapies (DAT) and the Role of Continuous Objective Monitoring (COM) Using Wearable Sensors.” Journal of Personalized Medicine 11, no. 7 (2021): 680. https://doi.org/10.3390/jpm11070680. 22. Muḥammad b. Muḥammad al- Mukhtār al- Shanqīṭī. Sharḥ Zād al- Mustaqnīʿ – al- tafrīgh. n.p.: n.d. 23. Muḥammad b. Ṣāliḥ al- ʿUthaymīn. Al- sharḥ al- ṣawtī li- Zād al- mustaqniʿ. 1421 AH. 24. Muḥammad Yusrī Ibrāhīm. Fiqh al- nawāzil liʾl - aqalliyyāt al-muslima. Cairo: Dār al-Yusr, 1434 H/2013 M. 25. PELAKSANAAN BADAL HAJI SEBAGAI PROFIT DITINJAU DARI HUKUM ISLAM (the Implementation of the Badal Hajj As Profit in Terms of Islamic Law). n.d. https://doi.org/10.30762/qawanin.v5i1.3423. 26. Rickard, J.,M.Bassiouny,R. J. Tedford,B.Baranowski,D. Spragg,D.Cantillon,N.Varma, B. L. Wilkoff, andW. H.W. Tang. “Long -TermOutcomes in Patients withAmbulatoryNewYork Heart Association Class III and IV Heart Failure Undergoing Cardiac Resynchronization Therapy.” American Journal of Cardiology 115, no. 1 (2015): 82 – 85. https://doi.org/10.1016/j.amjcard.2014.09.052. 27. Sowjanya, B., U. Sreenivasulu, J. N. Naidu, and N. Sivaranjani. “End Stage Renal Disease, Differential Diagnosis, a Rare Genetic Disorder: Bardet-Biedl Syndrome: Case Report and Review.” Indian Journal of Clinical Biochemistry 26, no. 2 (2011): 214 – 16. https://doi.org/10.1007/s12291-011-0116-4. 28. Sayyid Ḥusayn al- ʿAffānī. Nidāʾ al- Rayyān fī fiqh al- ṣawm wa- faḍl Ramaḍān, 312. 29. Scherr, B. F., and P. K. Buehler. “Ethical BoundaryDecisions in IntensiveCare Medicine.” Innere Medizin (Germany) 65, no. 10 (2024): 967 – 75 . https://doi.org/10.1007/s00108- 024-01781-5. 30. Shams al- Dīn al- Shirbīnī. Mughnī al- Muḥtāj. Beirut: Dār al-Kutub al- ʿIlmiyyah, 1994. 31. Tempesta, A., A. Tolomeo, A. Stefanucci, L. Marinaccio, and A. Mollica. “Use of Radiopharmaceuticals in the Diagnosis of Neurodegenerative Diseases.” European Journal of Medicinal Chemistry Reports 12 (2024): 100239.